Successful treatment of switching from benzodiazepine to orexin receptor antagonists improves cognitive function in psychiatric disorders: four case reports-Reference-Cited by-同舟云学术

Successful treatment of switching from benzodiazepine to orexin receptor antagonists improves cognitive function in psychiatric disorders: four case reports

Published:2022-12-16 Issue:3 Volume:38 Page:192-194
ISSN:0268-1315
Container-title:International Clinical Psychopharmacology
language:en
Short-container-title:

Author:

Hori Hikaru

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Pharmacology (medical),Psychiatry and Mental health

Reference13 articles.

1. The diagnosis and management of benzodiazepine dependence.;Ashton;Curr Opin Psychiatry,2005

2. Pharmacological interventions for benzodiazepine discontinuation in chronic benzodiazepine users.;Baandrup;Cochrane Database Syst Rev,2018

3. Hypnotic medication use among inpatients with schizophrenia and major depressive disorder: results of a nationwide study.;Furihata;Sleep Med,2022

4. Hypnosedative prescribing in outpatient psychiatry.;Huthwaite;Int Clin Psychopharmacol,2013

5. The characteristics of patients receiving psychotropic pro re nata medication at discharge for the treatment of schizophrenia and major depressive disorder: a nationwide survey from the EGUIDE project.;Ichihashi;Asian J Psychiatr,2022

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hypocretin‐1/Hypocretin Receptor 1 Regulates Neuroplasticity and Cognitive Function through Hippocampal Lactate Homeostasis in Depressed Model;Advanced Science;2024-08-09

2. Contribution of changes in the orexin system and energy sensors in the brain in depressive disorder - a study in an animal model;Pharmacological Reports;2024-01-09

3. Interplay of environmental and clinical factors in psychiatric disorders;International Clinical Psychopharmacology;2023-03-06

4. Comparative efficacy and safety of suvorexant and lemborexant for insomnia treatment;Psychiatry and Clinical Neurosciences Reports;2023-03